Hydreight Technologies Inc. (TSXV:NURS)
Canada
· Delayed Price · Currency is CAD | Market Cap | 215.83M |
| Revenue (ttm) | 24.48M |
| Net Income (ttm) | 453.24K |
| Shares Out | 53.42M |
| EPS (ttm) | 0.01 |
| PE Ratio | 476.20 |
| Forward PE | 19.24 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 237,476 |
| Average Volume | 149,266 |
| Open | 4.000 |
| Previous Close | 4.040 |
| Day's Range | 3.820 - 4.390 |
| 52-Week Range | 1.460 - 5.590 |
| Beta | 0.53 |
| RSI | 64.35 |
| Earnings Date | May 1, 2026 |
About Hydreight Technologies
Hydreight Technologies Inc. provides operates in the digital health technology sector in the United States. The company develops a proprietary telemedicine service that allows users to book confidential health and wellness, and/or medical services through a mobile application. It also provides consulting and advice in setting up health and wellness services, including assistance with finding experienced advisors in the areas of medical and privacy law, among others; medical liability insurance; pharmaceutical IV programs vetted by duly licensed... [Read more]
Financial Performance
In 2024, Hydreight Technologies's revenue was 16.04 million, an increase of 39.40% compared to the previous year's 11.51 million. Losses were -405,169, -79.09% less than in 2023.
Financial StatementsNews
Hydreight Announces Normal Course Issuer Bid
LAS VEGAS and VANCOUVER, BC, March 9, 2026 /PRNewswire/ - Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) ("Hydreight" or the "Company"), a provider of compliant digital health infr...
Hydreight Technologies Issues Fiscal 2026 Revenue Guidance of ≈ $150 Million and Provides Q1 2026 Outlook
VANCOUVER, British Columbia, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) (“Hydreight” or the “Company”), a provider of compliant digital health...
Hydreight Announces $10 Million Bought Deal Private Placement
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDT...
Hydreight Technologies Enters the At-Home STI Testing Market With Exclusive Distribution and 50,000 Pre-Orders
VANCOUVER, British Columbia, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”), a digital health platform enabling on-demand care, pharmacy fulfillment, and ...
Hydreight Exceeds 1.3 Million Product Orders Placed, Surpassing 2025 Operational Targets
VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) (“Hydreight” or the “Company”), a leading provider of compliant digita...
Victory Square Technologies Reports Q3 2025 Financial Results & Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - Victory Square Technologies Inc. (CSE: VST) (FSE: 6F6) (OTC Pink: VSQTF) ("Victory Square" or the "Company") today released its finan...
Hydreight Technologies Earnings Call Transcript: Q3 2025
Q3 saw 132% revenue growth year-over-year, four straight profitable quarters, and strong performance across all verticals, especially with the first full quarter of direct-to-consumer revenue. Over 510,000 orders and 1,100+ licenses validate the platform's scale, with 2026 revenue expected to double.
Hydreight Technologies Acquires 5% Equity Stake in Perfect Scripts, LLC, with Option to Increase up to 40%, and Establishes Strategic Partnership
Not for distribution to United States newswire services or for dissemination in the United States.
Hydreight Reports 132% YoY Revenue Increase in Q3 2025 and Fourth Consecutive Quarter of Profitability, Highlighting Strong Multi-Vertical Performance
“The quarter reflects broad growth across all verticals, expanding VSDHOne adoption, and strategic investments aimed at supporting margin improvement and 2026 objectives. We exceeded our internal metr...
Hydreight Technologies Ranked #77 Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™
VANCOUVER, British Columbia and LAS VEGAS, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV: NURS | OTCQB: HYDTF | FSE: SO6) today announced it ranked...
Hydreight Reports Corporate Update and Ranks #25 on Deloitte's 2025 Technology Fast 50™
Over 295,000 VSDHOne product orders between July and September, accelerating nurse network growth and a strong balance sheet with approximately CA$18.7 million in cash; Hydreight continues to build th...
Hydreight Announces Annual General Meeting Results
VANCOUVER, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDTF, FSE: SO6) (“Hydreight” or the “Company”), is pleased to announce that at the 2025 A...
Hydreight Technologies Signs Binding Letter of Intent to Acquire Dynamic IV Therapy Support AI Agent
Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, British Columbia, Sept.
Hydreight Announces Closing of its Oversubscribed $11.5 Million Convertible Debenture Offering, Including Full Exercise of Over-Allotment Option
VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDTF, FSE: SO6) (“Hydreight” or the “Company”), a leader in nationwide digital healthcare...
Hydreight Technologies Signs Definitive Agreement to Acquire 5% Equity Stake in Perfect Scripts, LLC, with Option to Increase to 40%, and Establish Strategic Partnership
Not for distribution to United States newswire services or for dissemination in the United States.
Victory Square Technologies Reports Q2 2025 Results Highlighted by Revenue Growth, Profitability, and Portfolio Momentum
Key Highlights: Six-Month Adjusted Revenue: $13.9M (+33% YoY) Hydreight: Third Consecutive Profitable Quarter Insu: Advancing Oral Insulin Toward Clinical Milestones Pawsible: Fund and Incubator Launc...
Hydreight Technologies Earnings Call Transcript: Q2 2025
Q2 results exceeded expectations with strong revenue growth, positive cash flow, and successful launch of the third vertical, VSDHOne. Strategic investments, acquisitions, and new product offerings are driving expansion, with guidance for 1.3 million orders by year-end unchanged.
Hydreight Achieves 33% YoY H1 Revenue Growth, Records 3rd Consecutive Quarter of Profitability, and Strengthens Performance Across Verticals
“We had a great first 6 months, with 33% year-over-year growth. We have also exceeded our internal metrics across all verticals in the first seven months of the year, reinforcing the strength of our s...
Hydreight Announces up to $10 Million Convertible Debenture Offering
VANCOUVER, British Columbia, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDTF, FSE: SO6) (“Hydreight” or the “Company”), a leader in nationwide digital healthcare ...
Hydreight Technologies Transcript: Investor Update
A strategic acquisition of a stake in Perfect Scripts enables full-scale pharmacy integration, boosting order volumes, improving margins, and expanding supply chain control. The deal supports rapid growth, operational scalability, and positions the platform for higher profitability and market leadership.
Hydreight Reports 34% Year-Over-Year Q1 Revenue Growth, Improvement in Bottom Line Results, and Delivers Strong Performance Across Verticals
“It was an outstanding quarter. We exceeded our Q1 projections with approximately 34% YOY growth from our first two verticals, a clear sign that our strategy is working. We also secured new customers ...
Hydreight Launches Personalized Genetic Testing and Wellness Solution on VSDHOne Platform
Expands access to precision-based care through at-home DNA testing and personalized health plans Expands access to precision-based care through at-home DNA testing and personalized health plans
Hydreight Technologies to Present at Maxim Group's 2025 Virtual Tech Conference & the CEM Bermuda Capital Event
VANCOUVER, British Columbia and LAS VEGAS, May 14, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a fast-growing digital he...
Hydreight Technologies Earnings Call Transcript: Q4 2024
Revenue grew to over $22M in 2024 with positive adjusted EBITDA and strong cash reserves. 2025 targets 30% growth, expansion of product offerings, and execution across three business verticals, supported by strategic investments and new partnerships.
Hydreight Technologies Appoints Dr. Roebuck As a Director of the Company
VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) ("Hydreight" or the "Company"), a North American, fully integrated, mob...